The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Nicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders
Open accessAbstract
Cigarette smoking rates in the American population are approximately 23%, whereas rates of smoking in clinical and population studies of individuals with neuropsychiatric disorders are typically two- to four-fold higher. Studies conducted in a variety of neuropsychiatric populations [e.g. attention-deficit hyperactivity disorder (ADHD), Alzheimer’s disease, schizophrenia] have collectively suggested that nicotine may be efficacious in remediating selected cognitive deficits associated with these disorders, thus providing a framework for understanding the specific vulnerability of these patients to smoking initiation and maintenance. However, the specific gain in cognitive performance produced by nicotine administration in healthy subjects with normal cognitive function is less clear. This article reviews our current understanding of central nicotinic acetylcholine receptor (nAChRs) systems in normal and neuropsychiatric disease states and, specifically, their role with respect to cognitive dysfunction and clinical symptoms in several specific neuropsychiatric populations, including ADHD, Alzheimer’s disease, Parkinson’s disease, Tourette’s Disorder, schizophrenia and affective disorders. The potential benefits of nicotinic agents for therapeutic use in neuropsychiatric disorders is discussed, as well as directions for further research in this area.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
What are the functional consequences of neurocognitive deficits in schizophrenia?
(1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.3.321 · Cited by 3,516
Schizophrenia as a Complex Trait: Evidence From a Meta-analysis of Twin Studies
Sullivan, P. F., Kendler, K. S., & Neale, M. C. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.12.1187 · Cited by 2,356
Kendler, K. S., Prescott, C. A., Myers, J., & Neale, M. C. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.9.929 · Cited by 1,868
Barkley, R. A., Fischer, M., Smallish, L., & Fletcher, K. (2002) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.111.2.279 · Cited by 1,199
Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus
Freedman, R., Coon, H., Myles-Worsley, M., Orr-Urtreger, A., Olincy, A., Davis, A., Polymeropoulos, M., Holik, J., Hopkins, J., Hoff, M., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.2.587 · Cited by 1,141
Smoking and Major Depression: A Causal Analysis
Kendler, K. S. (1993) · Archives of General Psychiatry · doi:10.1001/archpsyc.1993.01820130038007 · Cited by 792
Schizophrenia, sensory gating, and nicotinic receptors
Adler, L. E., Olincy, A., Waldo, M., Harris, J. G., Griffith, J., Stevens, K., Flach, K., Nagamoto, H., Bickford, P., Leonard, S., et al. (1998) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033320 · Cited by 690
Nicotine dependence, major depression, and anxiety in young adults
Breslau, N. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810360033005 · Cited by 634
Zoli, M., Moretti, M., Zanardi, A., McIntosh, J. M., Clementi, F., & Gotti, C. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-20-08785.2002 · Cited by 407
Nicotinic receptors in the brain. Links between molecular biology and behavior
Picciotto, M. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00146-3 · Cited by 354
Research works printed but not linked: 176
- 10.1177/01454455960204001 · DOI
- 10.1176/ajp.150.12.1856 · DOI · Paper page
- 10.2165/00002512-199711060-00004 · DOI
- 10.1038/sj.npp.1300265 · DOI
- 10.1016/S0166-2236(00)01716-1 · DOI · Paper page
- 10.1016/0091-3057(85)90139-X · DOI · Paper page
- 10.1212/WNL.30.8.839 · DOI
- 10.1080/02791072.1999.10471731 · DOI
- Beckham J C, 1995, Addict Behav, 20, 1, 10.1016/0306-4603(94)00037-Y · DOI
- 10.1002/jts.2490080308 · DOI
- 10.1016/S0306-4603(96)00071-8 · DOI · Paper page
- 10.1080/14622299050011141 · DOI · Paper page
- 10.1016/0304-3940(92)90179-B · DOI
- 10.1007/978-3-7091-0643-3_11 · DOI
- Breese C R, 1997, J Pharmacol Exp Ther, 282, 7
- 10.1016/S0893-133X(00)00121-4 · DOI · Paper page
- 10.1212/WNL.43.2.293 · DOI · Paper page
- 10.1001/archpsyc.56.12.1141 · DOI · Paper page
- 10.1016/S1353-8020(03)00028-2 · DOI
- 10.1007/BF02245195 · DOI
- Conners C K, 1995, The Continuous Performance Test
- Conners C K, 1996, Psychopharmacol Bull, 32, 67
- 10.1192/bjp.179.1.35 · DOI
- 10.1016/S0006-3223(00)01116-1 · DOI · Paper page
- 10.1016/S0006-3223(00)01101-X · DOI · Paper page
- 10.1176/ajp.155.11.1490 · DOI · Paper page
- 10.1080/14622200210141635 · DOI
- Delagarza V W, 2003, Am Family Phys, 68, 1365
- 10.1007/s002130050631 · DOI
- 10.1177/026988119901300106 · DOI
- 10.1016/S0893-133X(02)00372-X · DOI · Paper page
- Donnelly Roberts D L, 1998, J Pharmacol Exp Ther, 285, 777
- 10.1007/s002130100719 · DOI
- 10.1017/S0033291796003984 · DOI
- 10.1124/mol.64.6.1283 · DOI
- 10.1002/1531-8257(199911)14:6<1011::AID-MDS1016>3.0.CO;2-F · doi:10.1002/1531-8257(199911)14:6<1011::aid-mds1016>3.0.co;2-f
- 10.1007/BF02806011 · doi:10.1007/bf02806011
- 10.1016/S0091-3057(02)00711-6 · DOI
- 10.1016/S0893-133X(01)00257-3 · DOI · Paper page
- 10.1073/pnas.061369098 · DOI · Paper page
- 10.1007/BF02244882 · DOI
- First M, 1994, Diagnostic and statistical manual of mental disorders
- 10.1007/BF02805972 · DOI · Paper page
- 10.1038/379733a0 · DOI · Paper page
- 10.1073/pnas.93.24.14065 · DOI · Paper page
- 10.1016/S0166-4328(00)00206-0 · DOI · Paper page
- 10.1046/j.1471-4159.1999.0721117.x · DOI
- Fryer J D, 1999, J Pharmacol Exp Ther, 288, 88
- 10.1016/0091-3057(95)02063-2 · DOI
- 10.1016/j.tips.2003.11.003 · DOI · Paper page
- George T P, 2001, Psychiatr Times, 18, 39
- 10.1016/S0006-8993(98)00537-X · DOI
- George T P, 2000, J Pharmacol Exp Ther, 295, 58
- 10.1016/S0893-133X(01)00296-2 · DOI · Paper page
- George T P, 2003, American College of Neuropsychopharmacology
- George T P, 2003, Medical illness in schizophrenia
- 10.1007/s002130050554 · DOI
- 10.1093/bmb/65.1.21 · DOI
- 10.1016/S0006-3223(99)00130-4 · DOI · Paper page
- 10.4088/JCP.v59n0503 · DOI
- 10.1212/WNL.52.1.115 · DOI · Paper page
- 10.1093/oxfordjournals.aje.a116960 · DOI · Paper page
- 10.1176/ajp.154.6.799 · DOI · Paper page
- 10.1007/BF02251289 · DOI · Paper page
- 10.1007/s00213-002-1005-6 · DOI · Paper page
- 10.1046/j.1471-4159.1996.67051953.x · DOI · Paper page
- 10.1016/S0899-3289(20)30005-5 · DOI
- 10.1080/14622299050011971 · DOI
- 10.1007/s002130000541 · DOI
- 10.1037/0022-006X.61.5.743 · DOI · Paper page
- 10.1007/s002130050493 · DOI
- 10.1016/S0006-8993(97)01135-9 · DOI · Paper page
- 10.1017/S1041610201007888 · DOI
- 10.1007/s002130000399 · DOI
- 10.1146/annurev.pu.10.050189.000555 · DOI
- 10.1007/BF02247426 · DOI · Paper page
- Kelton M C, 2000, Brain Cognit, 43, 274
- 10.1016/S0306-4603(01)00266-0 · DOI
- 10.1016/S0091-3057(99)00006-4 · DOI
- 10.1159/000054957 · DOI
- 10.1007/s002130050109 · DOI
- 10.1007/s002130050800 · DOI
- 10.1007/s002130050360 · DOI
- 10.1001/jama.284.20.2606 · DOI · Paper page
- 10.1016/S0896-6273(02)01004-8 · DOI · Paper page
- 10.1007/BF02244994 · DOI
- 10.1080/14622200110050213 · DOI · Paper page
- 10.1001/archpsyc.59.12.1085 · DOI · Paper page
- 10.1007/BF02247415 · DOI · Paper page
- 10.1002/neu.10151 · DOI · Paper page
- 10.1007/s002130050667 · DOI · Paper page
- 10.1007/BF02246285 · DOI
- 10.1007/BF02246281 · DOI · Paper page
- 10.1016/S0893-133X(96)00018-8 · DOI · Paper page
- 10.1007/s002130050750 · DOI · Paper page
- 10.1016/S0926-6410(98)00044-5 · DOI
- 10.1037/1064-1297.9.1.83 · doi:10.1037/1064-1297.9.1.83 · Paper page
- Lezak M D, 1995, Neuropsychological assessment
- 10.1007/s002130051107 · DOI
- 10.1002/neu.10148 · DOI · Paper page
- McConville B J, 1991, Am J Psychiatry, 148, 793, 10.1176/ajp.148.6.793 · DOI
- 10.1016/0006-3223(92)90315-Q · DOI
- 10.1007/s002130100899 · DOI
- 10.1016/S0028-3932(98)00012-8 · DOI
- 10.1007/BF02247425 · DOI
- 10.1038/npp.1994.11 · DOI
- 10.2165/00002512-199711030-00005 · DOI · Paper page
- 10.1007/BF00174504 · DOI · Paper page
- 10.1080/14622299050011371 · DOI
- 10.1038/sj.npp.1300173 · DOI
- 10.1016/S0893-133X(97)00095-X · DOI
- 10.1016/S0165-1781(03)00022-2 · DOI
- 10.1016/S0893-133X(99)00098-6 · DOI
- 10.1124/mol.54.6.1132 · DOI · Paper page
- 10.3109/15622970309167951 · DOI
- 10.1159/000118807 · DOI
- 10.1007/s004150050299 · DOI · Paper page
- 10.1080/1462220021000018425 · DOI
- Perkins K A, 1994, J Pharmacol Exp Ther, 270, 628
- 10.1007/BF00445565 · DOI
- Picciotto M R, 2003, Trends Pharmacol Sci, 23, 494
- 10.1007/s002130050722 · DOI
- 10.1016/0306-4603(94)90058-2 · DOI
- 10.1300/J069v20n01_07 · DOI
- 10.1016/0899-3289(95)90030-6 · DOI · Paper page
- 10.1046/j.1360-0443.2002.00117.x · DOI
- 10.1007/BF02245662 · DOI
- 10.1017/S0317167100046321 · DOI
- 10.1212/WNL.37.2.226 · DOI
- 10.1523/JNEUROSCI.22-21-09604.2002 · DOI
- 10.1007/s002210000407 · DOI · Paper page
- 10.1002/ana.410190502 · DOI · Paper page
- 10.1016/S0014-2999(02)01452-8 · DOI
- 10.1097/00008877-200011000-00009 · DOI · Paper page
- Sacco K A, 2004, Nicotinic recepter mechanisms and neuropsychological functioning in schizophrenia: effects on spatial working memory and attention
- 10.1192/bjp.154.6.797 · DOI · Paper page
- 10.1002/hup.424 · DOI
- Salin-Pascual R J, 1996, J Clin Psychiatry, 57, 387
- 10.1124/jpet.102.045773 · DOI · Paper page
- 10.1124/jpet.103.051912 · DOI
- 10.1016/S0006-3223(02)01342-2 · DOI
- 10.1007/BF02247722 · DOI
- 10.3109/15622970209150616 · DOI
- 10.1097/00004583-200109000-00020 · DOI
- Simon R, 2002, Clinical neurology
- 10.1016/S0893-133X(02)00324-X · DOI · Paper page
- Snaedal J J T, 1996, Dementia, 7, 47
- 10.1016/0376-8716(89)90090-2 · DOI
- 10.1177/070674370200601S13 · DOI
- 10.1111/j.1360-0443.1994.tb00869.x · DOI
- 10.1007/BF02316865 · DOI
- 10.1176/ajp.155.8.1009 · DOI · Paper page
- 10.1007/s002130050573 · DOI · Paper page
- 10.1016/S0014-2999(99)00886-9 · DOI
- Suter T W, 1983, Activas Nervosa Superior, 25, 261
- 10.1177/026988119200600210 · DOI · Paper page
- 10.1124/jpet.102.041616 · DOI · Paper page
- 10.1016/S0278-5846(01)00194-4 · DOI
- 10.1176/appi.ajp.157.3.368 · DOI · Paper page
- 10.1080/10673220127912 · DOI · Paper page
- Vezina P, 1992, JPET, 261, 484
- Victor M, 2001, Adams and Victor’s principles of neurology
- 10.1212/WNL.57.6.1032 · DOI
- 10.1159/000109692 · DOI
- 10.1016/0091-3057(91)90109-F · DOI
- 10.1037/0894-4105.14.3.409 · DOI · Paper page
- Weiss M, 2003, adults. Can Med Assoc J, 168, 715
- 10.1007/BF00432014 · DOI
- 10.1007/s002130000382 · DOI · Paper page
- 10.1007/BF00432045 · DOI
- 10.1007/s002130050931 · DOI · Paper page
- 10.1016/0091-3057(95)00043-V · DOI · Paper page
- 10.1523/JNEUROSCI.23-08-03176.2003 · DOI · Paper page
- Yang Y K, 2002, Neuropsychpharmacology, 27, 684
- 10.1124/jpet.103.048777 · DOI
- 10.1177/1073858402239588 · DOI
Cited by
Co‐Morbidity of Smoking in Patients with Psychiatric and Substance Use Disorders
Kalman, D., Morissette, S. B., & George, T. P. (2005) · The American Journal on Addictions · doi:10.1080/10550490590924728 · Cited by 594
Self-citationMillan, M. J. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.11.006 · Cited by 551
Nicotine use in schizophrenia: The self medication hypotheses
Kumari, V., & Postma, P. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.02.006 · Cited by 468
Schroeder, S. A., & Morris, C. D. (2010) · Annual Review of Public Health · doi:10.1146/annurev.publhealth.012809.103701 · Cited by 349
Neuromodulatory Influences on Integration and Segregation in the Brain
Shine, J. M. (2019) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2019.04.002 · Cited by 317
Metadata
- Authors
- Sacco, K. A., Bannon, K. L., & George, T. P.
- Venue
- Journal of Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2004-12
- Volume
- 18
- Issue
- 4
- Pages
- 457-474
- ISSN
- 0269-8811 (ISSN-L)
- 1461-7285
- OpenAlex
- W4319292982
- Cited by
- 201
- References
- 21
- FWCI
- 6.34
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Nicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders. https://app.cochat.ai/papers/10.1177/0269881104047273
- The paper
- Sacco, K. A., Bannon, K. L., & George, T. P. (2004). Nicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders. Journal of Psychopharmacology. https://doi.org/10.1177/0269881104047273
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.